NASDAQ: ACLX - Arcellx, Inc.

Yield per half year: +64.97%
Sector: Healthcare

Share chart Arcellx, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Arcellx, Inc., биотехнологическая компания клинической стадии, занимается разработкой различных иммунотерапевтических средств для пациентов с раком и другими неизлечимыми заболеваниями. Ведущим кандидатом продукта ddCAR компании является CART-ddBCMA, который находится в фазе 1 клинических испытаний для лечения пациентов с рецидивирующей или рефрактерной (r/r) множественной миеломой (ММ).

More details
Он также разрабатывает ACLX-001, иммунотерапевтическую комбинацию, состоящую из клеток ARC-T и двухвалентных белков SparX, нацеленных на BCMA для лечения р/р ММ; ACLX-002 и ACLX-003 для лечения р/р острого миелоидного лейкоза (ОМЛ) и миелодиспластического синдрома (МДС); и другие продукты-кандидаты для лечения ОМЛ/МДС, а также программы солидных опухолей. Ранее компания называлась Encarta Therapeutics, Inc., а в январе 2016 года сменила название на Arcellx, Inc.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Цена ао 89.91
Сайт https://arcellx.com
P/BV 6.37
EV/EBITDA 1.96
EBITDA -0.0176
Див.доход ао 0
ISIN US03940C1009
Выручка 0.0179
P/S 72.94
Число акций ао 0.04806 млрд
Валюта usd
IPO date 2022-02-04
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Change price per day: +4.3% (86.2)
Change price per week: +11.66% (80.52)
Change price per month: +16.93% (76.89)
Change price per 3 month: +37.25% (65.51)
Change price per half year: +64.97% (54.5)
Change price per year: +155.72% (35.16)
Change price per year to date: +68.43% (53.38)
All parameters

Underestimation

Title Value Grade
P/S 25.26 1
P/BV 5.74 2
P/E 0 0
EV/EBITDA -28.35 0
Total: 3.25

Efficiency

Title Value Grade
ROA, % -8.57 0
ROE, % -14.56 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -1.11 10
Total: 8.8

Growth impulse

Title Value Grade
Yield Revenue, % 515.89 10
Yield Ebitda, % 397.79 10
Yield EPS, % -11.75 0
Total: 6
More

Institutions Volume Share, %
Perceptive Advisors LLC 4544809 8.61
FMR, LLC 4379169 8.29
NEA Management Company, LLC 3745262 7.09
Paradigm Biocapital Advisors LP 3658624 6.93
SR One Capital Management, LP 3146630 5.96
Blackrock Inc. 3018538 5.72
Suvretta Capital Management, LLC 2435974 4.61
Vanguard Group Inc 2061819 3.91
State Street Corporation 1773839 3.36
Cormorant Asset Management, LP 1700000 3.22

ETF Share, % Profitability for 1 year, % Dividends, %
Virtus LifeSci Biotech Clinical Trials ETF 1.2287 77.329244365683 0.33
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.21983 37.61291904149 1.59225
ProShares Ultra Nasdaq Biotechnology 0.28632 58.954326923077 0.85651
BNY Mellon US Small Cap Core Equity ETF 0.12482 37.872537301924 1.75333
Range Cancer Therapeutics ETF 1.58436 58.680203045685 0.11955
Dimensional U.S. Core Equity 2 ETF 0.00689 37.528779739064 1.47098
Dimensional US Core Equity Market ETF 0.00602 35.65815324165 1.40618
Dimensional U.S. Equity ETF 0.00324 36.134982184029 1.3557
iShares ESG Aware MSCI USA Small-Cap ETF 0.07387 39.294631710362 1.49366
Fidelity MSCI Health Care Index ETF 0.03704 21.181088923024 1.46057
First Trust US Equity Opportunities ETF 0.4065 -95.123309626365 0.69524
Fidelity Small-Mid Multifactor ETF 0.17418 39.592616168046 1.59943
First Trust Nasdaq Pharmaceuticals ETF 0.73064 21.085907396092 2.19901
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.11869 41.265441455097 1.41955
ProShares Hedge Replication ETF 0.02107 6.8665973306333 1.47892
Humankind US Stock ETF 0.01398 22.971795629061 1.99919
Invesco Nasdaq Biotechnology ETF 0.44098 29.399255715045 0.8565
iShares Morningstar Small-Cap ETF 0.07388 37.681332167863 1.60498
iShares Russell 2000 Growth ETF 0.27611 47.42032299557 0.6026
iShares Russell 3000 ETF 0.00637 37.942616648456 1.43482
iShares Morningstar Small-Cap ETF 0.07388 410.50632631881 1.60498
JPMorgan Diversified Return U.S. Small Cap Equity ETF 0.34065 34.797657082002 2.20258
Direxion Daily S&P Biotech Bull 3x Shares 0.58248 5201.8382352941 0.25924
Invesco Russell 2000 Dynamic Multifactor ETF 0.03448 30.7149376331 1.64004
Schwab U.S. Small-Cap ETF 0.07308 -30.367553865653 1.51433
Schwab U.S. Broad Market ETF 0.00491 -53.970149253731 1.43354
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.114 32.318928788801 1.66828
iShares U.S. Tech Breakthrough Multisector ETF 0.06434 46.089448312801 0.73986
ProShares UltraPro Russell2000 0.08071 125.96465921385 1.47873
Vanguard U.S. Momentum Factor ETF 0.11 52.778724259342 1.05834
Vanguard Russell 3000 ETF 0.01 38.467141890837 1.43817
Vanguard Russell 2000 Growth ETF 0.22 46.764050831914 0.60264
Vanguard Russell 2000 ETF 0.11 41.410408042578 1.48801
Principal Healthcare Innovators ETF 0.44959 631.79771324797 0.8416
Future Tech ETF 0.44959 412.888593871 0.8416



Head Job title Payment Year of birth
Mr. Rami Elghandour Chairman of the Board, CEO & President 1.02M 1979 (45 years)
Mr. Neeraj P. Teotia Chief Commercial Officer 461.95k 1975 (49 years)
Dr. Christopher R. Heery M.D. Chief Medical Officer 688.55k 1980 (44 years)
Ms. Michelle Lim Gilson Chief Financial Officer 832.8k 1993 (31 year)
Mr. Narinderjeet Singh M.S. Chief Technical Officer N/A 1972 (52 years)
Mr. David Tice Ph.D. Chief Scientific Officer N/A 1971 (53 years)
Ms. Myesha Lacy Chief Investor & Communications Officer N/A
Ms. Maryam Abdul-Kareem J.D., M.S. General Counsel & Chief Legal Officer N/A
Ms. Kate Aiken Chief People Officer N/A
Ms. Aileen Fernandes Chief Business Officer N/A

Address: United States, Gaithersburg. MD, 25 West Watkins Mill Road - open in Google maps, open in Yandex maps
Website: https://arcellx.com